esg
Prestige Biologics is strengthening corporate sustainability based on ESG.
Advancing Sustainable Innovation
Prestige Biologics is shaping a sustainable future through innovative biopharmaceutical manufacturing technologies and responsible management practices.
We believe our role extends beyond manufacturing medicines. By providing patients with greater access to treatment opportunities and delivering reliable services to our customers, we create meaningful value for society.
Built on quality, innovation, and trust, we contribute to the advancement of the global biopharmaceutical industry while creating long-term value for all stakeholders.
ENVIRONMENT
Considering Environmental Effects
Building a Sustainable Manufacturing Environment for Carbon Neutrality
Under our vision of Innovation for Life, Prestige Biologics practices environmentally responsible management to support carbon neutrality. Through energy efficiency initiatives and carbon reduction efforts, we minimize environmental impact while pursuing sustainable growth.
Creating Environmental Value Through Technological Innovation
Sustainable manufacturing begins with an efficient and reliable production environment.
Across our two campuses and four manufacturing plants, Prestige Biologics continuously implements engineering improvements aimed at enhancing operational efficiency and reducing energy consumption.
Through ALITA Smart BioFactory™, we advance the digitalization and automation of manufacturing processes. By establishing a data-driven operating environment and a systematic quality management framework, we improve production efficiency while contributing to reduced energy consumption throughout biopharmaceutical manufacturing operations.
These digital manufacturing innovations help reduce unnecessary resource consumption, support more efficient production environments, and strengthen both operational performance and quality reliability.
Responsible Supply Chain Management
Prestige Biologics maintains a stable and resilient supply chain through trusted partnerships with key raw material and manufacturing suppliers.
We also consider environmental impacts throughout the supply chain and incorporate sustainability practices and carbon reduction efforts within suppliers' production processes as important evaluation criteria during supplier selection.
Building a Sustainable Supply Chain
Through collaboration with global partners such as Cytiva and Thermo Fisher Scientific, we strengthen supply chain stability while pursuing shared efforts to create a more sustainable manufacturing ecosystem.
Environmental Contributions Through Manufacturing Innovation
We continue to drive process innovation through the development of digitally enabled manufacturing environments.
Leveraging ALITA Smart BioFactory™, we enhance data utilization and process optimization to support sustainable manufacturing practices. These technological advancements continue to evolve with carbon neutrality as a long-term objective.
Practical Environmental Management Across Operations
We promote practical and actionable environmental management initiatives throughout our workplaces and manufacturing facilities.
Through energy conservation, reduction of single-use products, utilization of reusable resources, and recycling initiatives, we reduce environmental impact while fostering a culture of sustainability.
SOCIAL
Respect for Diversity & Inclusivity
A Culture that Embraces Diversity
We foster an organizational culture built on mutual respect, collaboration, and appreciation for diversity. When individuals from diverse backgrounds, including different genders, nationalities, religions, and age groups, work together with respect and understanding, they unlock greater creativity and innovation.
We recognize diversity as a core driver of competitiveness and value the unique experiences and perspectives that each individual contributes to our culture.
Promoting Understanding Through Cross-Regional and Cross-Organizational Exchange
Prestige Biologics actively expands collaboration and exchange among its locations in Singapore, Seoul, Osong, and Busan.
Through global campus exchange programs and various internal initiatives, we strengthen communication and understanding among employees while continuously expanding our capabilities as a global biopharmaceutical company through technical, academic, and cultural engagement.
Developing Talent for Shared Growth
We view our employees as our most valuable asset and provide diverse learning and development opportunities to support professional growth and capability enhancement.
Through GMP Academy, Biomanufacturing Academy, role-specific training programs, and external learning opportunities, we help employees strengthen their expertise. We also provide flexible learning environments through online learning platforms that enable continuous development regardless of time or location.
A Global Collaboration Culture
We promote collaboration across diverse organizations through our global network spanning Korea, Singapore, and beyond.
Programs such as the Singapore-Korea SingKo Exchange foster knowledge sharing and collaboration, while ongoing communication initiatives help strengthen global teamwork capabilities across the organization.
Talent Development
We operate a wide range of learning and development programs to enhance employee expertise and professional capabilities.
By creating a safe working environment and promoting preventive safety management practices, we provide a workplace where employees can perform with confidence. Continuous development opportunities also support long-term professional growth within the biopharmaceutical industry.
Communication & Engagement
Through our internal newsletter, we share company updates, business activities, departmental news, and scientific insights.
A variety of content—including company events, employee clubs, and employee interviews—helps strengthen communication across global campuses, foster organizational culture, and promote mutual understanding and engagement among employees.
GOVERNANCE
Improving Transparency of Governance
Transparent and Responsible Management
We maintain a transparent and accountable management system to support sustainable growth.
Through the operation of our Audit Committee, we strengthen independent oversight while enhancing stakeholder trust through transparent disclosure of key business activities and corporate information.
Sound Risk Management and Financial Transparency
Prestige Biologics maintains a sound financial management framework in compliance with applicable external audit regulations and accounting standards.
Through systematic risk management activities, we proactively respond to changes in the business environment while reinforcing a stable foundation for sustainable growth.
Quality and Compliance Management
We manage quality and safety throughout the entire biopharmaceutical manufacturing process based on globally recognized GMP quality systems.
By complying with domestic and international regulatory requirements and conducting business with integrity and responsibility, we provide reliable biopharmaceutical manufacturing services to customers and partners. We continuously strengthen our quality management systems to support sustainable corporate value creation.
Fair and Transparent Disclosure
We are committed to providing accurate and transparent information to investors and stakeholders.
We maintain guidelines governing both information disclosure and confidentiality related to Investor Relations (IR) and Public Relations (PR), while adhering to disclosure principles based on applicable regulations and internal policies. Through fair and equitable communication, we continue to build trust with our stakeholders.
Audit and Internal Controls
We operate robust audit and internal control systems to enhance management transparency.
By complying with applicable laws and internal regulations, we manage business risks through independent and objective audit activities. We also provide regular training on IR practices and information management to strengthen compliance awareness across the organization.
Building Trust with Stakeholders
We place great importance on building trust with investors, customers, employees, and other stakeholders.
Through IR activities and public disclosures, we provide transparent corporate information and foster trust with the market. By adhering to disclosure principles grounded in relevant regulations and internal policies, and by maintaining fair and balanced communication, we continue to strengthen stakeholder confidence and corporate credibility.